121 related articles for article (PubMed ID: 19240787)
1. [Treating distal calciphylaxis with therapy associated with sevelamer and bisphosphonates].
León LR
Nefrologia; 2009; 29(1):92-3. PubMed ID: 19240787
[No Abstract] [Full Text] [Related]
2. Sodium thiosulfate, bisphosphonates, and cinacalcet for calciphylaxis.
Raymond CB; Wazny LD; Sood AR
CANNT J; 2009; 19(4):25-7; quiz 28-9. PubMed ID: 20136032
[No Abstract] [Full Text] [Related]
3. Calciphylaxis of both proximal and distal distribution.
Al-Hwiesh AK
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):82-6. PubMed ID: 18087130
[TBL] [Abstract][Full Text] [Related]
4. Severe nonuremic calciphylaxis due to hyperphosphatemia resolving with multimodality treatment including phosphate binders.
Wanat KA; Stewart CL; Negoianu D; Rosenbach M
JAMA Dermatol; 2014 Jun; 150(6):671-3. PubMed ID: 24647547
[No Abstract] [Full Text] [Related]
5. Successful treatment of calciphylaxis with pamidronate.
Schliep S; Schuler G; Kiesewetter F
Eur J Dermatol; 2008; 18(5):554-6. PubMed ID: 18693159
[TBL] [Abstract][Full Text] [Related]
6. Calciphylaxis responding to sodium thiosulfate therapy.
Baker BL; Fitzgibbons CA; Buescher LS
Arch Dermatol; 2007 Feb; 143(2):269-70. PubMed ID: 17310015
[No Abstract] [Full Text] [Related]
7. Case of proximal calciphylaxis with protein S deficiency, successfully treated with multimodality therapy.
Kuba Y; Terao H; Takahara M; Kiryu H; Furue M
J Dermatol; 2012 Jul; 39(7):657-9. PubMed ID: 21972994
[No Abstract] [Full Text] [Related]
8. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure.
Monney P; Nguyen QV; Perroud H; Descombes E
Nephrol Dial Transplant; 2004 Aug; 19(8):2130-2. PubMed ID: 15252173
[No Abstract] [Full Text] [Related]
9. What is the role of using sodium thiosulfate or bisphosphonates in the treatment for calciphylaxis?
Ross EA
Semin Dial; 2011; 24(4):434-6. PubMed ID: 21851407
[No Abstract] [Full Text] [Related]
10. Pamidronate as a treatment option in calciphylaxis.
da Costa JB; da Costa AG; Gomes MM
J Eur Acad Dermatol Venereol; 2008 Sep; 22(9):1128-30. PubMed ID: 18070019
[No Abstract] [Full Text] [Related]
11. Sodium thiosulfate not always resolves calciphylaxis: an ambiguous response.
Miceli S; Milio G; La Placa S; Di Raimondo D; Tuttolomondo A; Li Vecchi M; Licata G; Pinto A
Ren Fail; 2011; 33(1):84-7. PubMed ID: 21219211
[TBL] [Abstract][Full Text] [Related]
12. Three cases of penile calciphylaxis: diagnosis, treatment strategies, and the role of sodium thiosulfate.
O'Neil B; Southwick AW
Urology; 2012 Jul; 80(1):5-8. PubMed ID: 22748863
[No Abstract] [Full Text] [Related]
13. Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data.
Salmhofer H; Franzen M; Hitzl W; Koller J; Kreymann B; Fend F; Hauser-Kronberger C; Heemann U; Berr F; Schmaderer C
Kidney Blood Press Res; 2013; 37(4-5):346-59. PubMed ID: 24247072
[TBL] [Abstract][Full Text] [Related]
14. Use of sodium thiosulfate in the treatment of calciphylaxis.
Musso CG; Enz P; Vidal F; Gelman R; Lizarraga A; Giuseppe LD; Kowalczuk A; Garfi L; Galimberti R; Algranati L
Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1065-8. PubMed ID: 19861872
[TBL] [Abstract][Full Text] [Related]
15. Normo-renal calciphylaxis: response to sodium thiosulfate.
Ong S; Coulson IH
J Am Acad Dermatol; 2011 May; 64(5):e82-4. PubMed ID: 21496692
[No Abstract] [Full Text] [Related]
16. Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.
Hanafusa T; Yamaguchi Y; Tani M; Umegaki N; Nishimura Y; Katayama I
J Am Acad Dermatol; 2007 Dec; 57(6):1021-5. PubMed ID: 18021849
[TBL] [Abstract][Full Text] [Related]
17. Sevelamer: a promising but unproven drug.
Palmer SC; Craig JC; Strippoli GF
Nephrol Dial Transplant; 2007 Oct; 22(10):2742-5. PubMed ID: 17906325
[No Abstract] [Full Text] [Related]
18. Sevelamer versus calcium-based phosphate binders in chronic kidney disease: what should we conclude from the evidence to date?
Johnson DW
Nephrol Dial Transplant; 2009 Oct; 24(10):2970-2. PubMed ID: 19633092
[No Abstract] [Full Text] [Related]
19. Lack of mortality benefit with sevelamer.
Nolan CR; McCarron DA
Kidney Int; 2008 May; 73(9):1093; author reply 1093-4. PubMed ID: 18414441
[No Abstract] [Full Text] [Related]
20. [Phosphorus (P) chelant in dialysis: efficacy and cost. Peritoneal dialysis solutions].
Montenegro J
Nefrologia; 2008; 28 Suppl 5():53-7. PubMed ID: 18847421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
